Sponsors

Responding to increased HbA1c testing workload: instrument evaluation

In recent years there has been a dramatic increase in requests for HbA1c testing, due to its use in diabetes diagnosis and monitoring. Here, Colin Stone discusses the evaluation of HbA1c analysers to meet the needs of his department.

King’s College Hospital NHS Foundation Trust serves a large part of South London. The pathology department is part of the GSTS group, which also includes departments at St Thomas’ Hospital and Guy’s Hospital.

The workload related to the monitoring of diabetics using HbA1c was increasing, and, with the proposed introduction of the local ‘Diabetes Modernisation Initiative’, it was apparent that workload would increase dramatically. The department operated two Primus Ultra HbA1c analysers, based in the main biochemistry laboratory and in the diabetic clinic, but both were working close to capacity.

Clinical requirement was an important issue. The HbA1c workload was increasing dramatically and therefore an instrument was required that could meet the needs of general practitioners and clinicians in the diabetic clinic. This was particularly important in the diabetic clinic setting, where a result is needed almost immediately.

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

Pathology Visions 24

Hyatt Regency, Orlando, FL
3-5 November, 2025

UK NEQAS Cellular Pathology Technique - Annual Participant’s Meeting

America Square Conference Centre, London, EC3N 2LB.
4 - 5 November, 2024

Medica

Messe Dusseldorf
11-14 November, 2024

POCT-for-Scot: Bringing the future to you

SEC Arena, Glasgow
14 November, 2024

Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo

Hyatt Regency, Vancouver, Canada
19-23 November, 2024